This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chang, K. Articles by Willingham, M. C. Search for Related Content PubMed PubMed Citation Articles by Chang, K. Articles by Willingham, M. C.

Characterization of the Antigen (CAK1) Recognized by Monoclonal Antibody K1 Present on Ovarian Cancers and Normal Mesothelium

Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland 20892

K1 is a monoclonal antibody that reacts with a cell surface antigen (CAK1) found in human mesothelia and nonmucinous ovarian tumors. In this article, the characteristics of the CAK1 antigen have been examined in detail. Using immunofluorescence microscopy, we have found that the CAK1 signal is removed from the cell surface by treatment with proteases or by phosphatidylinositol-phospholipase C, but not by neuraminidase and ß-galactosidase. The phosphatidylinositol-phospholipase C-released material was found to contain the CAK1 antigen which was detected by a competition radioimmunoassay. The phosphatidylinositol-phospholipase C-released CAK1 antigen was examined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblotting and found to be a 40 kDa protein. The CAK1-K1 antibody complex remains on the cell surface and is poorly internalized, as shown by an acid wash immunofluorescence internalization assay. An immunotoxin composed of K1 and Lys-PE40, a mutant form of Pseudomonas exotoxin lacking the cell binding domain, was not cytotoxic, supporting the conclusion that the CAK1-K1 antibody complex is not internalized. However, an immunotoxin composed of K1 and native Pseudomonas exotoxin was selectively cytotoxic to cells expressing the CAK1 antigen. This cytotoxicity is due to the fact that domain I of Pseudomonas exotoxin promotes internalization of antigens which are not internalized or bound to antibody alone. Our results suggest that CAK1 is a polypeptide that is expressed on mesothelial cells and many ovarian cancers, and that K1 may be useful as a targeting agent for the immunotherapy of human ovarian cancer.

¹ To whom requests for reprints should be addressed, at Laboratory of Molecular Biology, Building 37, Room 4E16, National Cancer Institute, NIH, Bethesda, MD 20892.

Received 5/ 8/91. Accepted 10/21/91.

This article has been cited by other articles:

				I. Hellstrom, E. Friedman, T. Verch, Y. Yang, J. Korach, J. Jaffar, E. Swisher, B. Zhang, G. Ben-Baruch, M. C.B. Tan, et al. Anti-Mesothelin Antibodies and Circulating Mesothelin Relate to the Clinical State in Ovarian Cancer Patients Cancer Epidemiol. Biomarkers Prev., June 1, 2008; 17(6): 1520 - 1526. [Abstract] [Full Text] [PDF]

				M. Li, U. Bharadwaj, R. Zhang, S. Zhang, H. Mu, W. E. Fisher, F. C. Brunicardi, C. Chen, and Q. Yao Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer Mol. Cancer Ther., February 1, 2008; 7(2): 286 - 296. [Abstract] [Full Text] [PDF]

				I. Hellstrom, J. Raycraft, S. Kanan, N. Y. Sardesai, T. Verch, Y. Yang, and K. E. Hellstrom Mesothelin variant 1 is released from tumor cells as a diagnostic marker. Cancer Epidemiol. Biomarkers Prev., May 1, 2006; 15(5): 1014 - 1020. [Abstract] [Full Text] [PDF]

				I. Hellstrom, J. Raycraft, M. Hayden-Ledbetter, J. A. Ledbetter, M. Schummer, M. McIntosh, C. Drescher, N. Urban, and K. E. Hellstrom The HE4 (WFDC2) Protein Is a Biomarker for Ovarian Carcinoma Cancer Res., July 1, 2003; 63(13): 3695 - 3700. [Abstract] [Full Text] [PDF]

				C. Di Paolo, J. Willuda, S. Kubetzko, I. Lauffer, D. Tschudi, R. Waibel, A. Pluckthun, R. A. Stahel, and U. Zangemeister-Wittke A Recombinant Immunotoxin Derived from a Humanized Epithelial Cell Adhesion Molecule-specific Single-Chain Antibody Fragment Has Potent and Selective Antitumor Activity Clin. Cancer Res., July 1, 2003; 9(7): 2837 - 2848. [Abstract] [Full Text] [PDF]

				D. Fan, S. Yano, H. Shinohara, C. Solorzano, M. Van Arsdall, C. D. Bucana, S. Pathak, E. Kruzel, R. S. Herbst, A. Onn, et al. Targeted Therapy against Human Lung Cancer in Nude Mice by High-Affinity Recombinant Antimesothelin Single-Chain Fv Immunotoxin Mol. Cancer Ther., June 1, 2002; 1(8): 595 - 600. [Abstract] [Full Text] [PDF]

				M. Papetti and I. M. Herman Controlling Tumor-Derived and Vascular Endothelial Cell Growth : Role of the 4F2 Cell Surface Antigen Am. J. Pathol., July 1, 2001; 159(1): 165 - 178. [Abstract] [Full Text] [PDF]

				N. Scholler, N. Fu, Y. Yang, Z. Ye, G. E. Goodman, K. E. Hellstrom, and I. Hellstrom Soluble member(s) of the mesothelin/megakaryocyte potentiating factor family are detectable in sera from patients with ovarian carcinoma PNAS, September 28, 1999; 96(20): 11531 - 11536. [Abstract] [Full Text] [PDF]

				P. S. Chowdhury, J. L. Viner, R. Beers, and I. Pastan Isolation of a high-affinity stable single-chain Fv specific for mesothelin from DNA-immunized mice by phage display and construction of a recombinant immunotoxin with anti-tumor activity PNAS, January 20, 1998; 95(2): 669 - 674. [Abstract] [Full Text] [PDF]